BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

217 related articles for article (PubMed ID: 9053534)

  • 1. [Clinical evaluation of sulbactam/cefoperazone for lower respiratory tract infections. Correlation between the efficacy of sulbactam/cefoperazone and beta-lactamase].
    Koga H; Tomono K; Hirakata Y; Kohno S; Abe K; Kawamoto S; Kusano S; Tanaka K; Morikawa N; Sugiyama H; Katsumata T; Sasayama K; Shimoguchi K; Hashimoto A; Matsumoto Y; Inoue Y; Ishiguro M; Hori H; Mashimoto H; Dotsu Y; Tanaka H; Imamura Y; Kanda T; Hara K
    Jpn J Antibiot; 1996 Aug; 49(8):800-7. PubMed ID: 9053534
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Clinical evaluation of sulbactam/cefoperazone in lower respiratory tract infections].
    Ishibashi T; Takamoto M; Shinoda A; Yoshida M; Ichikawa Y; Kido M; Ninomiya K; Kitahara Y; Hara N; Tsurutani H
    Jpn J Antibiot; 1990 Feb; 43(2):239-56. PubMed ID: 2194054
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparative in-vitro activity of cefoperazone-tazobactam and cefoperazone-sulbactam combinations against ESBL pathogens in respiratory and urinary infections.
    Patankar M; Sukumaran S; Chhibba A; Nayak U; Sequeira L
    J Assoc Physicians India; 2012 Nov; 60():22-4. PubMed ID: 23767198
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Studies on sulbactam/ampicillin in the field of pediatrics].
    Nakamura H; Miyazu M; Kasai K; Iwai N; Taneda Y
    Jpn J Antibiot; 1989 Mar; 42(3):662-74. PubMed ID: 2664250
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Clinical evaluation of combination therapy of sulbactam/cefoperazone and aminoglycoside in respiratory tract infections].
    Sukoh M; Inoue T; Morita Y; Ito K; Togano Y; Yamanaka K; Hirose S; Takahashi T; Mita S; Mano K
    Jpn J Antibiot; 1994 Feb; 47(2):170-80. PubMed ID: 8151910
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Studies on sulbactam/cefoperazone in the field of pediatrics].
    Iwai N; Taneda Y; Shibata M; Mizoguchi F; Katayama M
    Jpn J Antibiot; 1984 Oct; 37(10):1859-79. PubMed ID: 6094865
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Synergy between sulbactam and ampicillin or cefoperazone in antimicrobial activity against beta-lactamase producing microorganisms. Results with the use of microdilution broth method].
    Deguchi K; Yokota N; Koguchi M; Nakane Y; Fukushima Y; Fukayama S; Ishihara R; Oda S; Tanaka S; Sato K
    Jpn J Antibiot; 1990 Jul; 43(7):1214-24. PubMed ID: 2232151
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [beta-lactamase activity in sputum of patients with community-acquired lower respiratory tract infections].
    Deguchi K; Yokota N; Koguchi M; Suzuki Y; Fukayama S; Ishihara R; Oda S; Tanaka S; Nakane Y; Fukumoto T
    Jpn J Antibiot; 1994 Feb; 47(2):161-9. PubMed ID: 8151909
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Efficacy of sulbactam/cefoperazone in respiratory tract infections in elderly patients with underlying respiratory diseases].
    Yoshida T; Oono Y; Toyoda M; Sawa T; Yokoyama H
    Jpn J Antibiot; 1996 Jul; 49(7):710-4. PubMed ID: 8828072
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Effects of sulbactam/cefoperazone in patients with respiratory infections in aged and/or with underlying respiratory diseases].
    Akutsu I; Motojima S; Sagara H; Ogata H; Otsuka T; Fukuda T; Ikemori R; Makino S
    Jpn J Antibiot; 1989 Apr; 42(4):910-20. PubMed ID: 2769942
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Clinical efficacy of sulbactam/cefoperazone for the treatment of geriatric patients with respiratory tract infections].
    Takaki K; Umeno M; Tanaka M; Harashima S; Takeda T; Okada K; Sawae Y
    Jpn J Antibiot; 1995 Jul; 48(7):942-8. PubMed ID: 7563587
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Laboratory and clinical study of sulbactam/cefoperazone (SBT/CPZ) on bacterial prostatitis].
    Suzuki K; Horiba M
    Hinyokika Kiyo; 1991 Oct; 37(10):1333-43. PubMed ID: 1755429
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Clinical studies of sulbactam/cefoperazone therapy in pediatric bacterial infections].
    Nakamura A; Himi K; Matsumura C; Suzuki H; Kurosaki T; Sugaya N; Terashima I; Uehara S
    Jpn J Antibiot; 1984 Oct; 37(10):1793-800. PubMed ID: 6094859
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Combined effect of sulbactam/cefoperazone and other antibiotics against clinical isolates of multi-resistant strains. I. Effect of sulbactam against beta-lactams resistant strains and in vitro combined effect of sulbactam/cefoperazone with each of piperacillin, latamoxef, ceftazidime, fosfomycin and doxycycline].
    Kouda M; Kumagai I; Kobayashi J; Sugai R; Matsuzaki H
    Jpn J Antibiot; 1990 Apr; 43(4):636-58. PubMed ID: 2199689
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Antimicrobial activities of sultamicillin against clinical isolates from upper respiratory tract infections].
    Deguchi K; Yokota N; Koguchi M; Nakane Y; Fukayama S; Nishimura Y; Oda S; Tanaka S; Kato M; Sato K
    Jpn J Antibiot; 1988 Sep; 41(9):1194-204. PubMed ID: 3266508
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Sulbactam/cefoperazone versus cefotaxime for the treatment of moderate-to-severe bacterial infections: results of a randomized, controlled clinical trial.
    Li JT; Lu Y; Hou J; Chen YF; Miao JZ; Jia YX; Hou J; Zhang XZ; Chen DK; Hu WZ; Li LJ; Liu DM; Wang Z; Wu J; Gu JM; Wang HL; Zhang YL; Sun L
    Clin Infect Dis; 1997 Mar; 24(3):498-505. PubMed ID: 9114206
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Clinical evaluation of sulbactam/cefoperazone for infections during the chemotherapy of hematologic malignancy].
    Kawai Y; Ueda T; Iwasaki H; Nakamura T
    Jpn J Antibiot; 1994 Sep; 47(9):1196-201. PubMed ID: 7990260
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [In vitro susceptibility to cefoperazone and sulbactam/cefoperazone combination of bacterial strains isolated from various patient materials].
    Aksoy AM; Ozsan M; Ural O; Ekmen H
    Mikrobiyol Bul; 1993 Jul; 27(3):216-20. PubMed ID: 8361410
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Clinical study on sulbactam/cefoperazone in the field of pediatrics].
    Minamitani M; Hachimori K; Kaneda K
    Jpn J Antibiot; 1984 Oct; 37(10):1801-11. PubMed ID: 6094860
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Clinical studies on sulbactam/cefoperazone in the field of obstetrics and gynecology].
    Obata I; Ryu F; Imagawa N; Ochiai K; Koike K; Morimoto O; Hachiya S
    Jpn J Antibiot; 1984 Dec; 37(12):2478-94. PubMed ID: 6098741
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.